TKT and breast cancer: To address whether our established TK clusters could be used to predict the therapeutic effectiveness in response to drugs in breast cancer, we integrated the transcriptome data representing the mRNA expression from the CCLE (31) and doxorubicin-response signature from the GDSC (32).